Oncology Clinical Trials in Miami Beach, FL
As of August 2026, 37 paid clinical trials are recruiting for Oncology in Miami Beach, Florida. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
37 clinical trials for Oncology
·Clear filters·A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Top Research Study Locations in Miami Beach
Researchers run research studies in Miami Beach, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mount Sinai Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 37 |
| Mount Sinai Comprehensive Cancer Center | Cancer, Endometrial Cancer, B-cell Malignancy | 13 |
| Mount Sinai Braman Comprehensive Cancer Center | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 7 |
| Mount Sinai Cancer Center | Malignant Neoplasm, Ovarian Cancer, Ovarian Neoplasms | 4 |
| Mount Sinai Medical Center of Florida | Leukemia, Other, Minimal Residual Disease, TNBC - Triple-Negative Breast Cancer | 3 |
| Quantum Clinical Trials | Alzheimer's Disease Psychosis, Diabetes Mellitus, Type 2, Metabolic Syndrome | 3 |
| CZ Rheumatology | Lumbar Spinal Stenosis, Overweight or Obesity, Psoriatic Arthritis | 2 |
| 335 | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer | 1 |
| Ascentage Investigative Site | CLL/SLL | 1 |
| Broward Research Center | Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Broward Research Ctr. | Heart Failure, Obesity | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Floridian Clinical Research, LLC - Clinitiative Health Research (Network) | Active Rheumatoid Arthritis | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Harmony Clinical Research, Inc - North Miami Beach | Chronic Idiopathic Constipation (CIC) | 1 |
| Miami Beach | Endometriosis, Uterine Fibroids | 1 |
| Miami Beach Clinical Research Center | Moderately to Severely Active Crohns Disease | 1 |
| Mount Sinai | Low Grade Serous Ovarian Cancer | 1 |
| Mount Sinai Cancer Research Program | Colorectal Cancer | 1 |
| Mount Sinai Medical - Comprehensive Cancer Center | Breast Cancer | 1 |
| Mount Sinai Medical Center - Miami Beach | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| Mount Sinai Medical Center Comprehensive Cancer Center | Gastrointestinal Cancer | 1 |
| Mount Sinai Medical Center of Florida, Inc | Cervical Cancer | 1 |
| Mount Sinai Medical Center of Florida, Inc. | AV Block, Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Mount Sinai Miami | Refractory Angina | 1 |
Active & Upcoming Studies in Miami Beach (2026)
Recruiting trials in Miami Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (62 active studies)
- D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer · Phase 3 · InnoPharmax Inc.
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (5 active studies)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy · Phase 2 · Endevica Bio
Neurology & pain (1 active study)
- Alzheimer's Disease Neuroimaging Initiative 4 · University of Southern California
Eye & vision (1 active study)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
Common conditions studied in Miami Beach
- Endometrial Cancer (7 active studies)
- Ovarian Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Chronic Lymphocytic Leukemia (4 active studies)
- Fallopian Tube Cancer (3 active studies)
- Heart Failure (3 active studies)
Leading research sponsors in Miami Beach
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Miami Beach?
There are approximately 95 recruiting clinical trials in Miami Beach, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Miami Beach pay participants?
Most recruiting trials in Miami Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Miami Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Miami Beach?
The most common conditions under active study in Miami Beach include Endometrial Cancer (7), Ovarian Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Chronic Lymphocytic Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Miami Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Miami Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Miami Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Miami Beach?
Recruiting research sites in Miami Beach include Mount Sinai Medical Center, Mount Sinai Comprehensive Cancer Center, Mount Sinai Braman Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Miami Beach right now?
The largest active categories in Miami Beach are Cancer & tumors (62), Cardiovascular (5), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.